Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ISOMETAMIDIUM
ID: ALA2111043
Max Phase: Phase
Molecular Formula: C28H26N7+
Molecular Weight: 460.57
Molecule Type: Small molecule
Associated Items:
ID: ALA2111043
Max Phase: Phase
Molecular Formula: C28H26N7+
Molecular Weight: 460.57
Molecule Type: Small molecule
Associated Items:
Synonyms (2): Isometamidium cation | Isometamidium ion
Synonyms from Alternative Forms(2):
Canonical SMILES: CC[n+]1c(-c2ccccc2)c2cc(N/N=N/c3cccc(C(=N)N)c3)ccc2c2ccc(N)cc21
Standard InChI: InChI=1S/C28H25N7/c1-2-35-26-16-20(29)11-13-24(26)23-14-12-22(17-25(23)27(35)18-7-4-3-5-8-18)33-34-32-21-10-6-9-19(15-21)28(30)31/h3-17,29H,2H2,1H3,(H4,30,31,32,33)/p+1
Standard InChI Key: UGKOYGZYLRKTJH-UHFFFAOYSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.57 | Molecular Weight (Monoisotopic): 460.2244 | AlogP: 5.94 | #Rotatable Bonds: 6 |
Polar Surface Area: 116.52 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 10.78 | CX LogP: 0.78 | CX LogD: -1.59 |
Aromatic Rings: 5 | Heavy Atoms: 35 | QED Weighted: 0.05 | Np Likeness Score: -0.23 |
1. Bozorgi AH, Ghomi HT, Jouyban A. (2012) QSAR and pharmacophore studies of telomerase inhibitors, 21 (6): [10.1007/s00044-011-9594-4] |
2. Artese A, Costa G, Distinto S, Moraca F, Ortuso F, Parrotta L, Alcaro S.. (2013) Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data., 68 [PMID:23974014] [10.1016/j.ejmech.2013.07.022] |
3. Hulpia F, Campagnaro GD, Scortichini M, Van Hecke K, Maes L, de Koning HP, Caljon G, Van Calenbergh S.. (2019) Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity., 164 [PMID:30677668] [10.1016/j.ejmech.2018.12.050] |
4. Hulpia F,Bouton J,Campagnaro GD,Alfayez IA,Mabille D,Maes L,de Koning HP,Caljon G,Van Calenbergh S. (2020) C6-O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents., 188 [PMID:31931339] [10.1016/j.ejmech.2019.112018] |
Source(1):